Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · page 31 of 56
The chart uses a color-coded safety gradient on the Y-axis and efficacy percentages on the X-axis.
Pitch deck · competitive_analysis · compare_peers · overcrowded density
Slide locked Sign in to view
Slide schematic 6/6
callout 2/2 chart 1/1 list 1/1 source-note 1/1 title 1/1
Components 6
primary primary bar-horizontal bullet source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.